AMANDA CUELLAR: Open Payments
NPI 1275813560 · EL CENTRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $172 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $258 |
| Edwards Lifesciences Corporation | 1 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| Corcept Therapeutics | 2 | $44 |
| Novo Nordisk Inc | 1 | $25 |
Products named: INGREZZA, SAPIEN 3 Ultra RESILIA, Kerendia, Korlym, Ozempic.
Industry payments across CA — which companies pay providers there.
